Investing Biotech ETFs Slip as Trump Administration Pushes for Cheap Drug Imports By Max ChenDecember 18, 2019
Innovative ETFs Channel Biotech ETFs Pop After Novartis Acquires Medicines Co. By Max ChenNovember 25, 2019
Innovative ETFs Channel Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene By Max ChenNovember 1, 2019
Disruptive Technology Channel How ETF Investors Could Enhance a Portfolio with Disruptive Innovative Companies By Max ChenOctober 1, 2019
Disruptive Technology Channel Focusing on Disruptive Innovation for Changing Markets By Max ChenSeptember 30, 2019
Innovative ETFs Channel Drug Pricing Reforms Keep Pressure on Biotech, Healthcare ETFs By Max ChenSeptember 26, 2019
Innovative ETFs Channel AI Healthcare Technology Could Boost “AIIQ” ETF By Ben HernandezSeptember 19, 2019
Beyond Basic Beta Channel 8 ETFs to Capture Opportunities in Healthcare Sector By Max ChenAugust 22, 2019
Innovative ETFs Channel Healthcare Providers ETF Breaks Out After White House Ends Drug Rebate Rule By Max ChenJuly 11, 2019
Innovative ETFs Channel Biotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing Rule By Max ChenJuly 9, 2019
Alternatives Channel Sector ETFs Most at Risk of Earning Disappointments Ahead By Max ChenJuly 2, 2019
Innovative ETFs Channel AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs By Max ChenJune 25, 2019